MedPath

Investigation of a Polyphenol-rich Preparation as Support for Oncology Patients Undergoing Gastrointestinal Tumor Resection

Not Applicable
Recruiting
Conditions
Immunomodulation
Interventions
Dietary Supplement: Nutridrink Skin Repair
Dietary Supplement: Nutridrink Skin Repair with a mixture of plant extracts rich in polyphenolic compounds
Registration Number
NCT06017661
Lead Sponsor
AronPharma Sp. z o. o.
Brief Summary

The aim of the study is to demonstrate, under clinical conditions, the effectiveness of the standard product 'Nutridrink' enriched with a mixture of plant extracts rich in polyphenolic compounds in the aspect of supporting the recovery of oncology patients undergoing surgical resection of tumours.

Detailed Description

Oncology patients undergoing the procedure are exposed to various postoperative complications. Nutridrink with a mixture of extracts with anti-inflammatory and antioxidative properties aims to provide the patient with essential nutrients and bioactive substances that can reduce the inflammatory state, protect cells from oxidative damage, and decrease the risk of complications while supporting tissue healing processes after the surgical procedure. The study group are oncology patients undergoing surgical resection of gastrointestinal tumour. During the study, the effects of the mixture on levels of oxidative stress and inflammation markers will be assessed, as well as the subjective evaluation of patients' quality of life and well-being after surgical surgical tumor resection.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
30
Inclusion Criteria
  • Women and men, 18-80 years old
  • Patients diagnosed with resectable gastrointestinal tract cancer undergo the resection procedure no later than one month after being enrolled in the study
  • Signed informed consent
Exclusion Criteria
  • Intake of supplements containing plant extracts, polyphenols or anthocyanins
  • Participation in another clinical trial
  • Inability to consume the investigational product in liquid form as medication/placebo
  • Women who are pregnant, planning to become pregnant during the study or breastfeeding
  • Autoimmune disease, severe liver dysfunction, inflammatory bowel disease, tuberculosis, multiple sclerosis, AIDS, rheumatoid arthritis, organ transplantation
  • Hypersensitivity/allergy to any of the ingredient

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Nutridrink Skin RepairNutridrink Skin RepairGroup of 15 patients undergoing surgical resection of tumour
Nutridrink Skin Repair with a mixture of plant extracts rich in polyphenolic compoundsNutridrink Skin Repair with a mixture of plant extracts rich in polyphenolic compoundsGroup of 15 patients undergoing surgical resection of tumour
Primary Outcome Measures
NameTimeMethod
GSH levelBaseline, 3 weeks, 6 weeks

Comparison of GSH level

SOD levelBaseline, 3 weeks, 6 weeks

Comparison of SOD level

IL-6 levelBaseline, 3 weeks, 6 weeks

Comparison of IL-6 level

IL-8 levelBaseline, 3 weeks, 6 weeks

Comparison of IL-8 level

Secondary Outcome Measures
NameTimeMethod
Patients' quality of lifeBaseline, 3 weeks, 6 weeks

Subjective assessment of patients' quality of life after surgical resection of the tumor (questionnaire). Higher scores mean a better outcome.

Trial Locations

Locations (1)

Uniwersyteckie Centrum Kliniczne, Klinika Chirurgii Onkologicznej, Transplantacyjnej i Ogólne

🇵🇱

Gdańsk, Poland

© Copyright 2025. All Rights Reserved by MedPath